POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)
1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		1je6 MHC CLASS I
CHAIN-RELATED
PROTEIN
(Homo
sapiens)		5 / 12ALA A 135
LEU A 138
ALA A 139
THR A 143
GLN A  91
None
1.09A19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		2i6b ADENOSINE KINASE
(Homo
sapiens)		5 / 12ALA A 141
LEU A 138
ALA A 139
PHE A  49
ILE A 135
None
89I  A 500 (-4.4A)
None
None
None
0.97A20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		2ziu CROSSOVER JUNCTION
ENDONUCLEASE EME1
MUS81 PROTEIN
(Danio
rerio;
Homo
sapiens)		6 / 12ALA B 421
LEU B 359
ALA B 358
THR B 311
PHE B 439
GLN A 445
None
1.45A23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		4nzm INOSITOL
HEXAKISPHOSPHATE AND
DIPHOSPHOINOSITOL-PE
NTAKISPHOSPHATE
KINASE 2
(Homo
sapiens)		5 / 12PRO A 119
ALA A 300
LEU A 299
THR A 251
ILE A 122
None
1.22A19.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		4p0r CROSSOVER JUNCTION
ENDONUCLEASE EME1
(Homo
sapiens)		5 / 12ALA B 421
LEU B 359
ALA B 358
THR B 311
PHE B 439
None
1.23A22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2JJP_A_KLNA413_1
(CYTOCHROME P450
113A1)		5mvx DELTA-LIKE PROTEIN 4
(Homo
sapiens)		5 / 12ALA A  45
LEU A 139
THR A  56
GLN A 160
ILE A 119
None
1.20A18.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		1wl4 ACETYL-COENZYME A
ACETYLTRANSFERASE 2
(Homo
sapiens)		5 / 11PHE A  57
ARG A  15
ALA A  24
MET A 119
LEU A  33
None
1.40A21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		2ee4 RHO GTPASE
ACTIVATING PROTEIN 5
VARIANT
(Homo
sapiens)		5 / 11LEU A 162
ILE A 142
PHE A 166
GLU A  36
LEU A  87
None
1.42A15.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		2qob EPHRIN RECEPTOR
(Homo
sapiens)		5 / 11LEU A 814
ILE A 874
ALA A 731
ARG A 745
LEU A 747
None
1.38A22.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		2w8q SUCCINATE-SEMIALDEHY
DE DEHYDROGENASE,
MITOCHONDRIAL
(Homo
sapiens)		5 / 11PHE A  76
SER A 208
LEU A  58
ILE A 157
ALA A 139
None
1.44A21.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		3gqc DNA REPAIR PROTEIN
REV1
(Homo
sapiens)		5 / 11ILE A 610
PHE A 590
ALA A 591
GLU A 565
LEU A 557
None
1.42A22.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		3h55 ALPHA-N-ACETYLGALACT
OSAMINIDASE
(Homo
sapiens)		5 / 11PHE A 145
ALA A 142
ARG A 165
GLU A 164
LEU A 155
None
None
None
NAG  A 624 ( 4.1A)
None
1.13A22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		3k9b LIVER
CARBOXYLESTERASE 1
(Homo
sapiens)		5 / 11LEU A1117
ILE A1168
ALA A1149
GLU A1225
LEU A1172
None
1.33A25.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		3rk6 POLYADENYLATE-BINDIN
G
PROTEIN-INTERACTING
PROTEIN 1
(Homo
sapiens)		5 / 11ILE A 101
PHE A 104
ALA A 105
ARG A 166
LEU A 121
None
1.32A19.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		4gwn MEPRIN A SUBUNIT
BETA
(Homo
sapiens)		5 / 11LEU A 448
ILE A 441
ALA A 473
ARG A 511
LEU A 501
None
1.28A22.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		4jmk DUAL SPECIFICITY
PROTEIN PHOSPHATASE
8
(Homo
sapiens)		5 / 11SER A 228
LEU A 170
ILE A 256
ALA A 193
ARG A 207
None
1.40A15.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		4nfn TAU-TUBULIN KINASE 1
(Homo
sapiens)		5 / 11SER A 224
PHE A 199
ALA A 210
ARG A 240
GLU A 231
None
None
None
SO4  A 403 (-4.1A)
SO4  A 403 ( 4.9A)
1.36A21.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		4ny4 CYTOCHROME P450 3A4
(Homo
sapiens)		6 / 11ARG A 105
SER A 119
LEU A 210
ILE A 301
ALA A 305
MET A 371
HEM  A 601 ( 2.8A)
2QH  A 602 (-3.9A)
None
None
2QH  A 602 ( 3.6A)
None
1.03A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		4ny4 CYTOCHROME P450 3A4
(Homo
sapiens)		7 / 11PHE A  57
ARG A 105
SER A 119
ILE A 301
ALA A 305
MET A 371
ARG A 372
None
HEM  A 601 ( 2.8A)
2QH  A 602 (-3.9A)
None
2QH  A 602 ( 3.6A)
None
None
0.55A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		4ny4 CYTOCHROME P450 3A4
(Homo
sapiens)		6 / 11PHE A  57
ARG A 105
SER A 119
ILE A 301
PHE A 304
ALA A 305
None
HEM  A 601 ( 2.8A)
2QH  A 602 (-3.9A)
None
2QH  A 602 (-3.3A)
2QH  A 602 ( 3.6A)
1.19A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		4ny4 CYTOCHROME P450 3A4
(Homo
sapiens)		5 / 11SER A 119
ILE A 301
ALA A 305
MET A 371
GLU A 374
2QH  A 602 (-3.9A)
None
2QH  A 602 ( 3.6A)
None
2QH  A 602 ( 4.8A)
0.74A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		4ny4 CYTOCHROME P450 3A4
(Homo
sapiens)		5 / 11SER A 119
ILE A 301
PHE A 304
ALA A 305
GLU A 374
2QH  A 602 (-3.9A)
None
2QH  A 602 (-3.3A)
2QH  A 602 ( 3.6A)
2QH  A 602 ( 4.8A)
1.22A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		4ydj HEAVY CHAIN OF
ANTIBODY 44-VRC13.01
LIGHT CHAIN OF
ANTIBODY 44-VRC13.01
(Homo
sapiens)		5 / 11ILE H  35
ALA H  93
ARG L  53
GLU H 100
LEU L  46
None
1.27A18.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		5gqq HEME-BINDING PROTEIN
2
(Homo
sapiens)		5 / 11LEU A  69
ILE A  62
PHE A  66
GLU A 191
LEU A 185
None
1.09A18.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		5veu CYTOCHROME P450 3A5
(Homo
sapiens)		6 / 11ARG A 105
SER A 119
ILE A 301
ALA A 305
GLU A 374
LEU A 481
HEM  A 601 (-2.8A)
RIT  A 602 (-3.7A)
RIT  A 602 ( 4.9A)
HEM  A 601 (-3.4A)
RIT  A 602 ( 4.8A)
None
0.67A83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		5veu CYTOCHROME P450 3A5
(Homo
sapiens)		6 / 11ARG A 105
SER A 119
ILE A 301
PHE A 304
ALA A 305
LEU A 481
HEM  A 601 (-2.8A)
RIT  A 602 (-3.7A)
RIT  A 602 ( 4.9A)
RIT  A 602 (-3.7A)
HEM  A 601 (-3.4A)
None
0.73A83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		5veu CYTOCHROME P450 3A5
(Homo
sapiens)		6 / 11PHE A 215
ARG A 105
ILE A 301
PHE A 304
ALA A 305
LEU A 481
RIT  A 602 (-4.0A)
HEM  A 601 (-2.8A)
RIT  A 602 ( 4.9A)
RIT  A 602 (-3.7A)
HEM  A 601 (-3.4A)
None
1.49A83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		5veu CYTOCHROME P450 3A5
(Homo
sapiens)		6 / 11SER A 119
ILE A 301
PHE A 304
ALA A 305
ARG A 372
LEU A 481
RIT  A 602 (-3.7A)
RIT  A 602 ( 4.9A)
RIT  A 602 (-3.7A)
HEM  A 601 (-3.4A)
None
None
0.97A83.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1500_1
(CYTOCHROME P450 3A4)		6ces RAS-RELATED
GTP-BINDING PROTEIN
C
(Homo
sapiens)		5 / 11PHE C 134
ILE C 195
ALA C 199
MET C 171
GLU C 174
None
1.18A9.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		1v5w MEIOTIC
RECOMBINATION
PROTEIN DMC1/LIM15
HOMOLOG
(Homo
sapiens)		5 / 10ASP A 337
ILE A 116
LEU A 310
ILE A 221
GLY A 334
None
1.29A21.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		3bxw CHITINASE
DOMAIN-CONTAINING
PROTEIN 1
(Homo
sapiens)		5 / 10PHE B  81
ILE B 273
LEU B 370
ILE B 205
GLY B  61
None
1.36A23.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		4ccz METHIONINE SYNTHASE
(Homo
sapiens)		5 / 10PHE A  98
ILE A 222
LEU A 236
THR A 227
GLY A 147
None
1.35A21.67
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		4ny4 CYTOCHROME P450 3A4
(Homo
sapiens)		7 / 10PHE A  57
ASP A  76
ARG A 106
SER A 119
ILE A 120
THR A 224
ILE A 301
None
None
None
2QH  A 602 (-3.9A)
None
None
None
0.62A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		4ny4 CYTOCHROME P450 3A4
(Homo
sapiens)		5 / 10PHE A  57
ASP A  76
ARG A 106
THR A 224
GLY A 481
None
1.19A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		5l3q SIGNAL RECOGNITION
PARTICLE RECEPTOR
SUBUNIT ALPHA
(Homo
sapiens)		5 / 10ASP B 591
ILE B 585
THR B 592
ILE B 582
GLY B 430
GNP  B 705 (-2.9A)
None
GNP  B 705 ( 4.7A)
None
GNP  B 705 (-3.1A)
1.19A21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		5nem INTEGRIN BETA-6
(Homo
sapiens)		5 / 10SER B 213
ILE B 212
PHE B 154
LEU B 139
GLY B 155
None
1.33A22.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		6d6q EXOSOME COMPLEX
COMPONENT RRP4
EXOSOME COMPLEX
COMPONENT RRP42
(Homo
sapiens)		5 / 10ASP E 213
ARG E  27
LEU E 216
THR E 215
ILE H 280
None
1.33A10.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_A_KLNA1501_1
(CYTOCHROME P450 3A4)		6ejb XYLOSYLTRANSFERASE 1
(Homo
sapiens)		5 / 10PHE A 458
SER A 539
LEU A 525
THR A 524
GLY A 491
None
1.29A9.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		1t8t HEPARAN SULFATE
D-GLUCOSAMINYL
3-O-SULFOTRANSFERASE
3A1
(Homo
sapiens)		5 / 9LEU A 352
ILE A 336
ALA A 320
GLY A 164
LEU A 315
None
None
None
A3P  A1302 (-3.3A)
None
1.14A20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		1wl4 ACETYL-COENZYME A
ACETYLTRANSFERASE 2
(Homo
sapiens)		5 / 9PHE A  57
ARG A  15
ALA A  24
GLY A  34
LEU A  33
None
1.05A21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		1wl4 ACETYL-COENZYME A
ACETYLTRANSFERASE 2
(Homo
sapiens)		5 / 9PHE A  57
ARG A  15
LEU A 206
GLY A  34
LEU A  33
None
1.09A21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		3bpt 3-HYDROXYISOBUTYRYL-
COA HYDROLASE
(Homo
sapiens)		5 / 9SER A 151
ILE A 139
ALA A 213
GLY A 192
LEU A 187
None
1.12A24.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		3ebb PHOSPHOLIPASE
A2-ACTIVATING
PROTEIN
(Homo
sapiens)		5 / 9LEU A 647
ILE A 698
ALA A 701
GLU A 734
LEU A 728
None
1.29A20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		3j7y BL21
(Homo
sapiens)		5 / 9LEU S  95
ILE S  87
ALA S 201
GLY S 145
LEU S 149
None
1.26A19.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		3ngo CCR4-NOT
TRANSCRIPTION
COMPLEX SUBUNIT
6-LIKE
(Homo
sapiens)		5 / 9SER A 237
LEU A 332
ILE A 285
ALA A 329
LEU A 405
None
1.22A20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		3nmz APC VARIANT PROTEIN
(Homo
sapiens)		5 / 9SER A 643
LEU A 662
ALA A 680
GLY A 618
LEU A 620
None
1.29A20.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		3u88 HISTONE-LYSINE
N-METHYLTRANSFERASE
2A
LENS
EPITHELIUM-DERIVED
GROWTH FACTOR
(Homo
sapiens)		5 / 9PHE M 133
LEU C 383
ALA C 376
GLU C 395
LEU C 400
None
1.14A10.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		4d10 COP9 SIGNALOSOME
COMPLEX SUBUNIT 3
(Homo
sapiens)		5 / 9LEU C 107
ILE C 141
ALA C 127
GLY C  57
LEU C  56
None
1.23A22.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		4ny4 CYTOCHROME P450 3A4
(Homo
sapiens)		5 / 9PHE A  57
ARG A 105
LEU A 210
ILE A 301
ALA A 305
None
HEM  A 601 ( 2.8A)
None
None
2QH  A 602 ( 3.6A)
1.01A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		4ny4 CYTOCHROME P450 3A4
(Homo
sapiens)		6 / 9PHE A  57
ARG A 105
SER A 119
ILE A 301
ALA A 305
GLU A 374
None
HEM  A 601 ( 2.8A)
2QH  A 602 (-3.9A)
None
2QH  A 602 ( 3.6A)
2QH  A 602 ( 4.8A)
0.61A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		4o27 SERINE/THREONINE-PRO
TEIN KINASE 24
(Homo
sapiens)		5 / 9ARG B 290
LEU B 125
ALA B 147
GLY B 156
LEU B 152
None
1.04A20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		5c1b TRANSITIONAL
ENDOPLASMIC
RETICULUM ATPASE
(Homo
sapiens)		5 / 9LEU A 357
ILE A 303
GLU A 291
GLY A 334
LEU A 335
None
1.04A21.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		5emw TRANSCRIPTIONAL
ENHANCER FACTOR
TEF-5
(Homo
sapiens)		5 / 9LEU A 435
ALA A 296
GLU A 347
GLY A 284
LEU A 288
None
1.30A18.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		6ao5 SERINE/THREONINE-PRO
TEIN KINASE 3
(Homo
sapiens)		5 / 9ARG A 114
LEU A 127
ALA A 149
GLY A 158
LEU A 154
None
1.26A23.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens)		5 / 9SER A 921
LEU A 856
ILE A 897
GLY A 846
LEU A 875
None
1.10A9.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		6dd3 CYTOSOLIC PURINE
5'-NUCLEOTIDASE
(Homo
sapiens)		5 / 9PHE A 450
ALA A 166
GLU A 374
GLY A  99
LEU A 100
None
1.26A9.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		1bhq CD11B
(Homo
sapiens)		4 / 7PHE 1 275
THR 1 211
ILE 1 316
GLY 1 270
None
0.82A17.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		1ey2 HOMOGENTISATE
1,2-DIOXYGENASE
(Homo
sapiens)		4 / 7PHE A 154
ILE A 156
ILE A 190
GLY A 185
None
0.95A21.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		1hjo PROTEIN (HEAT-SHOCK
70KD PROTEIN)
(Homo
sapiens)		4 / 7ILE A   7
THR A 158
ILE A  29
GLY A  12
None
None
None
ADP  A 383 (-3.5A)
0.86A22.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		3g04 HUMAN THYROID
STIMULATING
AUTOANTIBODY M22
HEAVY CHAIN
THYROTROPIN RECEPTOR
(Homo
sapiens)		4 / 7PHE C 130
ILE C  85
THR C 159
GLY B  98
None
0.91A20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		4hwt THREONINE--TRNA
LIGASE, CYTOPLASMIC
(Homo
sapiens)		4 / 7PHE A 527
ILE A 579
ILE A 594
GLY A 560
None
0.88A21.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		4j8f HEAT SHOCK 70 KDA
PROTEIN 1A/1B,
HSC70-INTERACTING
PROTEIN
(Homo
sapiens;
Rattus
norvegicus)		4 / 7ILE A   7
THR A 158
ILE A  29
GLY A  12
None
None
None
PO4  A 603 (-3.3A)
0.93A21.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		4ny4 CYTOCHROME P450 3A4
(Homo
sapiens)		4 / 7PHE A  57
SER A 119
ILE A 120
ILE A 301
None
2QH  A 602 (-3.9A)
None
None
0.60A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		4ny4 CYTOCHROME P450 3A4
(Homo
sapiens)		4 / 7PHE A  57
SER A 119
THR A 224
ILE A 301
None
2QH  A 602 (-3.9A)
None
None
0.57A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		4qgk FATTY ALDEHYDE
DEHYDROGENASE
(Homo
sapiens)		4 / 7PHE A 364
ILE A 216
THR A 384
GLY A 232
None
0.88A21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1499_1
(CYTOCHROME P450 3A4)		6bhv POLY [ADP-RIBOSE]
POLYMERASE 1
(Homo
sapiens)		4 / 7PHE A1007
PHE A 869
ILE A 778
ILE A 801
None
1.00A10.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		1k27 5'-DEOXY-5'-METHYLTH
IOADENOSINE
PHOSPHORYLASE
(Homo
sapiens)		5 / 12LEU A 250
LEU A 251
ILE A 109
ALA A 216
THR A  93
None
None
None
None
PO4  A 301 (-3.8A)
1.08A20.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		2ass S-PHASE
KINASE-ASSOCIATED
PROTEIN 2
(Homo
sapiens)		5 / 12SER B2320
LEU B2340
LEU B2315
PHE B2331
THR B2394
None
1.21A22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		2dkw HYPOTHETICAL PROTEIN
KIAA1240
(Homo
sapiens)		5 / 12ARG A  29
LEU A  69
PHE A  68
ILE A 107
ALA A 106
None
1.11A15.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		2okk GLUTAMATE
DECARBOXYLASE 2
(Homo
sapiens)		5 / 12LEU A 371
LEU A 381
ALA A 366
THR A 391
MET A 361
None
None
LLP  A 396 ( 3.5A)
None
None
1.26A21.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		3d8b FIDGETIN-LIKE
PROTEIN 1
(Homo
sapiens)		5 / 12LEU A 485
PHE A 486
ILE A 499
ALA A 467
THR A 471
None
1.28A22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		3ngo CCR4-NOT
TRANSCRIPTION
COMPLEX SUBUNIT
6-LIKE
(Homo
sapiens)		5 / 12SER A 237
LEU A 332
LEU A 354
ILE A 285
ALA A 329
None
1.07A20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		3u9w LEUKOTRIENE A-4
HYDROLASE
(Homo
sapiens)		5 / 12LEU A1404
LEU A1407
ILE A1328
ALA A1244
GLU A1318
None
None
None
None
ZN  A2001 ( 2.2A)
1.28A21.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		4d4l 6-PHOSPHOFRUCTO-2-KI
NASE/FRUCTOSE-2,6-BI
SPHOSPHATASE 3
(Homo
sapiens)		5 / 12PHE A 284
LEU A 394
LEU A 250
PHE A 398
THR A 297
None
1.19A23.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		4kng LEUCINE-RICH
REPEAT-CONTAINING
G-PROTEIN COUPLED
RECEPTOR 5
(Homo
sapiens)		5 / 12ARG A 144
LEU A 185
LEU A 164
PHE A 158
ALA A 190
None
1.19A21.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		4ny4 CYTOCHROME P450 3A4
(Homo
sapiens)		6 / 12ARG A 105
SER A 119
LEU A 210
ILE A 301
ALA A 305
THR A 309
HEM  A 601 ( 2.8A)
2QH  A 602 (-3.9A)
None
None
2QH  A 602 ( 3.6A)
2QH  A 602 ( 3.7A)
1.01A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		4ny4 CYTOCHROME P450 3A4
(Homo
sapiens)		9 / 12PHE A  57
ARG A 105
SER A 119
PHE A 241
ILE A 301
ALA A 305
THR A 309
MET A 371
ARG A 372
None
HEM  A 601 ( 2.8A)
2QH  A 602 (-3.9A)
2QH  A 602 (-4.5A)
None
2QH  A 602 ( 3.6A)
2QH  A 602 ( 3.7A)
None
None
0.82A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		4ny4 CYTOCHROME P450 3A4
(Homo
sapiens)		6 / 12PHE A  57
PHE A 241
ALA A 305
THR A 309
MET A 371
GLU A 374
None
2QH  A 602 (-4.5A)
2QH  A 602 ( 3.6A)
2QH  A 602 ( 3.7A)
None
2QH  A 602 ( 4.8A)
1.18A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		4p13 MEDIUM-CHAIN
SPECIFIC ACYL-COA
DEHYDROGENASE,
MITOCHONDRIAL
(Homo
sapiens)		5 / 12LEU A  87
PHE A  30
ILE A  53
ALA A  97
GLU A  41
None
1.22A20.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		4rh7 GREEN FLUORESCENT
PROTEIN/CYTOPLASMIC
DYNEIN 2 HEAVY CHAIN
1
(Homo
sapiens;
synthetic
construct)		5 / 12LEU A4180
LEU A4183
PHE A4179
ILE A4217
ALA A4202
None
1.02A9.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		4zk3 SERPIN B3
(Homo
sapiens)		5 / 12SER A  30
LEU A 101
PHE A  92
ALA A 179
THR A 155
None
1.28A23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		5ajz 6-PHOSPHOFRUCTO-2-KI
NASE/FRUCTOSE-2,6-BI
SPHOSPHATASE 3
(Homo
sapiens)		5 / 12PHE A 284
LEU A 394
LEU A 250
PHE A 398
THR A 297
None
1.19A23.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		5b16 RIBONUCLEASE
3,DROSHA,RIBONUCLEAS
E
3,DROSHA,RIBONUCLEAS
E 3
(Homo
sapiens)		5 / 12PHE A 988
LEU A1067
LEU A1068
ILE A1048
ALA A1060
None
1.11A16.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		5veu CYTOCHROME P450 3A5
(Homo
sapiens)		7 / 12ARG A 105
SER A 119
PHE A 241
ILE A 301
ALA A 305
THR A 309
GLU A 374
HEM  A 601 (-2.8A)
RIT  A 602 (-3.7A)
RIT  A 602 (-3.9A)
RIT  A 602 ( 4.9A)
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
RIT  A 602 ( 4.8A)
0.72A83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		5veu CYTOCHROME P450 3A5
(Homo
sapiens)		6 / 12SER A 119
PHE A 241
ILE A 301
ALA A 305
THR A 309
ARG A 372
RIT  A 602 (-3.7A)
RIT  A 602 (-3.9A)
RIT  A 602 ( 4.9A)
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
None
0.78A83.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1498_1
(CYTOCHROME P450 3A4)		5xnp LEUCINE-RICH REPEAT
AND FIBRONECTIN
TYPE-III
DOMAIN-CONTAINING
PROTEIN 5
(Homo
sapiens)		5 / 12PHE A 191
LEU A 128
LEU A 152
ILE A 114
ALA A 142
None
1.26A10.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		1cjy PROTEIN (CYTOSOLIC
PHOSPHOLIPASE A2)
(Homo
sapiens)		4 / 7PHE A 205
LEU A 560
ILE A 354
GLY A 226
None
1.02A21.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		1htr GASTRICSIN
(Homo
sapiens)		4 / 7SER B  42
LEU B  80
PHE B  71
GLY B 109
None
0.92A21.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		1snz ALDOSE 1-EPIMERASE
(Homo
sapiens)		4 / 7SER A 177
PHE A 339
ILE A  40
GLY A 183
None
0.96A21.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		2asu HEPATOCYTE GROWTH
FACTOR-LIKE PROTEIN
(Homo
sapiens)		4 / 7PHE B 506
PHE B 524
ILE B 517
GLY B 533
None
0.91A18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		2wns OROTATE
PHOSPHORIBOSYLTRANSF
ERASE
(Homo
sapiens)		4 / 7PHE A  23
SER A  34
LEU A 180
GLY A 195
None
0.92A19.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		3g04 THYROTROPIN RECEPTOR
(Homo
sapiens)		4 / 7PHE C 141
LEU C 156
PHE C 172
GLY C 132
None
0.95A20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		4bmb GALECTIN-8
(Homo
sapiens)		4 / 7PHE A  19
PHE A 114
ILE A 130
GLY A 139
None
1.00A16.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		4btm TAU-TUBULIN KINASE 1
(Homo
sapiens)		4 / 7PHE A 223
PHE A 184
ILE A 169
GLY A 225
None
1.00A20.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		4e54 DNA DAMAGE-BINDING
PROTEIN 2
(Homo
sapiens)		4 / 7PHE B 110
PHE B 186
LEU B 162
GLY B 130
None
1.02A20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		4nen INTEGRIN ALPHA-X
(Homo
sapiens)		4 / 7PHE A 748
LEU A 698
PHE A 673
ILE A 635
None
0.84A17.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		5hdh TOLL-LIKE RECEPTOR 8
(Homo
sapiens)		4 / 7PHE A 568
LEU A 521
PHE A 526
ILE A 493
None
0.96A20.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		5jja SERINE/THREONINE-PRO
TEIN PHOSPHATASE 2A
56 KDA REGULATORY
SUBUNIT GAMMA
ISOFORM
(Homo
sapiens)		4 / 7PHE A 163
PHE A 140
SER A 147
PHE A  42
PHE  A 163 ( 1.3A)
PHE  A 140 ( 1.3A)
SER  A 147 ( 0.0A)
PHE  A  42 ( 1.3A)
0.93A22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		5szj MICAL
C-TERMINAL-LIKE
PROTEIN
RAS-RELATED PROTEIN
RAB-10
(Homo
sapiens)		4 / 7PHE A  38
PHE A  71
PHE B 650
ILE B 657
GNP  A 301 (-4.0A)
None
None
None
1.02A14.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_C_KLNC1499_1
(CYTOCHROME P450 3A4)		5xxi CYTOCHROME P450 2C9
(Homo
sapiens)		4 / 7LEU A 131
PHE A 263
ILE A 123
GLY A 437
None
None
None
HEM  A 504 (-3.5A)
1.02A30.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		1jmy BILE-SALT-ACTIVATED
LIPASE
(Homo
sapiens)		5 / 11LEU A 234
ALA A 241
ARG A 144
GLU A  43
LEU A 151
None
1.32A21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		2abl ABL TYROSINE KINASE
(Homo
sapiens)		5 / 11SER A 206
ALA A 225
THR A 231
ARG A 171
LEU A 184
None
1.38A13.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		2dkp PLECKSTRIN HOMOLOGY
DOMAIN-CONTAINING
FAMILY A MEMBER 5
(Homo
sapiens)		5 / 11LEU A  50
ILE A  72
ALA A  89
THR A  96
ARG A  83
None
1.29A12.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		2ery RAS-RELATED PROTEIN
R-RAS2
(Homo
sapiens)		5 / 11LEU A  17
ILE A 123
PHE A 168
ALA A 167
LEU A  30
None
1.29A17.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		3h55 ALPHA-N-ACETYLGALACT
OSAMINIDASE
(Homo
sapiens)		5 / 11PHE A 145
ALA A 142
ARG A 165
GLU A 164
LEU A 155
None
None
None
NAG  A 624 ( 4.1A)
None
1.13A22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		3ngo CCR4-NOT
TRANSCRIPTION
COMPLEX SUBUNIT
6-LIKE
(Homo
sapiens)		5 / 11SER A 237
LEU A 332
ILE A 285
ALA A 329
LEU A 405
None
1.07A20.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		4g34 EUKARYOTIC
TRANSLATION
INITIATION FACTOR
2-ALPHA KINASE 3
(Homo
sapiens)		5 / 11LEU A1013
ILE A1070
ALA A 921
GLU A 993
LEU A 937
None
1.29A22.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		4ny4 CYTOCHROME P450 3A4
(Homo
sapiens)		7 / 11ARG A 105
SER A 119
ILE A 301
ALA A 305
THR A 309
MET A 371
ARG A 372
HEM  A 601 ( 2.8A)
2QH  A 602 (-3.9A)
None
2QH  A 602 ( 3.6A)
2QH  A 602 ( 3.7A)
None
None
0.59A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		4ny4 CYTOCHROME P450 3A4
(Homo
sapiens)		5 / 11ARG A 105
SER A 119
ILE A 301
PHE A 304
ALA A 305
HEM  A 601 ( 2.8A)
2QH  A 602 (-3.9A)
None
2QH  A 602 (-3.3A)
2QH  A 602 ( 3.6A)
1.06A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		4ny4 CYTOCHROME P450 3A4
(Homo
sapiens)		7 / 11ARG A 105
SER A 119
LEU A 210
ILE A 301
ALA A 305
THR A 309
MET A 371
HEM  A 601 ( 2.8A)
2QH  A 602 (-3.9A)
None
None
2QH  A 602 ( 3.6A)
2QH  A 602 ( 3.7A)
None
1.03A100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		4ny4 CYTOCHROME P450 3A4
(Homo
sapiens)		5 / 11ILE A 301
ALA A 305
THR A 309
MET A 371
GLU A 374
None
2QH  A 602 ( 3.6A)
2QH  A 602 ( 3.7A)
None
2QH  A 602 ( 4.8A)
0.81A100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		4ydj HEAVY CHAIN OF
ANTIBODY 44-VRC13.01
LIGHT CHAIN OF
ANTIBODY 44-VRC13.01
(Homo
sapiens)		5 / 11ILE H  35
ALA H  93
ARG L  53
GLU H 100
LEU L  46
None
1.36A18.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		4zk3 SERPIN B3
(Homo
sapiens)		5 / 11SER A  30
LEU A 101
ILE A 180
PHE A 182
ALA A 343
None
1.38A23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		5gqq HEME-BINDING PROTEIN
2
(Homo
sapiens)		5 / 11LEU A  69
ILE A  62
PHE A  66
GLU A 191
LEU A 185
None
1.12A18.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		5veu CYTOCHROME P450 3A5
(Homo
sapiens)		7 / 11ARG A 105
SER A 119
ILE A 301
ALA A 305
THR A 309
GLU A 374
LEU A 481
HEM  A 601 (-2.8A)
RIT  A 602 (-3.7A)
RIT  A 602 ( 4.9A)
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
RIT  A 602 ( 4.8A)
None
0.65A83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		5veu CYTOCHROME P450 3A5
(Homo
sapiens)		7 / 11ARG A 105
SER A 119
ILE A 301
PHE A 304
ALA A 305
THR A 309
LEU A 481
HEM  A 601 (-2.8A)
RIT  A 602 (-3.7A)
RIT  A 602 ( 4.9A)
RIT  A 602 (-3.7A)
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
None
0.65A83.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		5veu CYTOCHROME P450 3A5
(Homo
sapiens)		7 / 11SER A 119
ILE A 301
PHE A 304
ALA A 305
THR A 309
ARG A 372
LEU A 481
RIT  A 602 (-3.7A)
RIT  A 602 ( 4.9A)
RIT  A 602 (-3.7A)
HEM  A 601 (-3.4A)
HEM  A 601 ( 3.5A)
None
None
0.95A83.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1498_1
(CYTOCHROME P450 3A4)		5xgs RCC1-LIKE G
EXCHANGING
FACTOR-LIKE PROTEIN
(Homo
sapiens)		5 / 11LEU A 159
ALA A  71
THR A 119
MET A 198
LEU A 142
None
1.25A20.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		1k3b DIPEPTYDIL-PEPTIDASE
I EXCLUSION DOMAIN
DIPEPTYDIL-PEPTIDASE
I LIGHT CHAIN
(Homo
sapiens)		4 / 5PHE A 113
SER B 268
PHE A  68
ILE B 282
None
1.02A12.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		2jfd FATTY ACID SYNTHASE
(Homo
sapiens)		4 / 5PHE A 553
SER A 714
PHE A 682
ILE A 717
None
1.16A21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		3hhd FATTY ACID SYNTHASE
(Homo
sapiens)		4 / 5PHE A 553
SER A 714
PHE A 682
ILE A 717
None
1.11A19.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		3ihp UBIQUITIN
CARBOXYL-TERMINAL
HYDROLASE 5
(Homo
sapiens)		4 / 5PHE A 829
PHE A 345
PHE A 440
ILE A 412
None
1.38A21.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		3kij PROBABLE GLUTATHIONE
PEROXIDASE 8
(Homo
sapiens)		4 / 5PHE A  47
PHE A 134
PHE A 106
ILE A 187
None
1.26A17.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		3lgg ADENOSINE DEAMINASE
CECR1
(Homo
sapiens)		4 / 5PHE A 289
PHE A 198
SER A 205
ILE A  92
None
1.30A22.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		3pdf DIPEPTIDYL PEPTIDASE
1
(Homo
sapiens)		4 / 5PHE A 113
SER A 268
PHE A  68
ILE A 282
None
1.02A22.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		3vfd SPASTIN
(Homo
sapiens)		4 / 5PHE A 469
SER A 399
PHE A 501
ILE A 359
None
1.21A22.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		4hva CASPASE-6
(Homo
sapiens)		4 / 5PHE A 288
PHE A 114
SER A 150
PHE A  78
None
1.34A18.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		4oem DIPEPTIDYL PEPTIDASE
1 HEAVY CHAIN
(Homo
sapiens)		4 / 5PHE A 113
SER A 268
PHE A  68
ILE A 282
None
EDO  A 509 (-4.1A)
None
None
1.05A20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		4xzp GALECTIN-4
(Homo
sapiens)		4 / 5PHE A  76
PHE A  46
PHE A 121
ILE A 147
None
1.05A15.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		5dux GALECTIN-4
(Homo
sapiens)		4 / 5PHE B  76
PHE B  46
PHE B 121
ILE B 147
None
1.07A16.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		5nug CYTOPLASMIC DYNEIN 1
HEAVY CHAIN 1
(Homo
sapiens)		4 / 5PHE A1960
PHE A1938
PHE A1945
ILE A4069
None
1.36A7.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_D_KLND1499_1
(CYTOCHROME P450 3A4)		5xtd NADH-UBIQUINONE
OXIDOREDUCTASE CHAIN
1
(Homo
sapiens)		4 / 5PHE s  56
PHE s 223
SER s 209
ILE s 213
None
1.13A22.40